The conference brought together national and international experts in drug prevention, treatment and care and featured a broad range of topics and formats.
Keynote sessions covered the following topics:
- Genetics and neurobiology
- Prevention and treatment innovations
- Prevention and treatment systems
- Social determinants
- Law enforcement, criminal justice and health cooperation
- Overdose prevention
- Special populations
Please find information on our keynote and plenary speakers below. To view or download the presentations, please click on the name of the individual speaker and open the attachment under their biography.
Honorary Research Associate University of Manchester, Consultant, UNODC Promoting Family Skills as a Prevention Measure for Substance Misuse and Child Protection for Families Affected by War and Displacement |
Director, ADP Consultancy UK Consultant, UNODC The Role of Quality Assurance in implementing evidence-based, ethical and cost-effective treatment for drug use disorders |
Professor, Drug Policy and Criminal Policy, Ghent University The Criminal Justice System and the Community as Turning Points |
|
World Health Organization (WHO) Community Management of Opioid Overdose Including an Overview of the S-O-S Initiative - Stop Overdose Safely |
|
World Health Organization (WHO) WHO Guidelines and Tools on Diagnosis and Management of Substance Use Disorders |
Associate Professor of Public Health, Department of Clinical and Biological Sciences University of Turin Implementation and evaluation of the "Unplugged" prevention program in Nigeria |
Principal Scientific Analyst Public Health Unit, EMCDDA Registry of evidence-based programmes |
Professor of Psychiatry, Rabat Faculty of Medicine Treatment innovations European neighbours and beyond |
Director, Brief Strategic Family Therapy Institute, University of Miami Miller School of Medicine United Nations Family Therapy for Adolescents with Drug Use Disorders including in Contact with the Criminal Justice System |
President Emeritus, Treatment Alternatives for Safe Communities (TASC) Creating a System of Alternatives to Incarceration (Therapeutic Justice) |
Programme Director, Behaviours and Health Risks, Burnet Institute Opioid overdose prevention and response: key implementation challenges |
|
Head of Prevention Programmes - Institute of Research and Development (UTRIP) Prevention Practice – Quo Vadis |
Director, COPOLAD Quality assurance mechanisms |
Professor, Norwegian Centre for Addiction Research Opioid overdose prevention: The need for a range of strategies. |
|
Professor of Drug Addiction Medicine at the School of Psychiatry of the University of Pisa, Italy Is Agonist Opioid Treatment Long Enough? The Role of Craving and Psychopathology |
President, Applied Prevention Science International (APSI) Prevention Innovations: Linking Science of Prevention to Practice |
Professor of Psychiatry and Paediatrics, Alcohol Research Centre & Injury Prevention Centre, University of Connecticut School of Medicine Youth Substance Use Disorders & Co-occurring Depression: The Nature of the Association and Treatment Implications
|
Professor of Psychiatry, Weill Cornell Medical College Drug Addiction in Personality Disorders
|
Collaborative to Advance Health Services, University of Missouri-Kansas City Transforming the Workforce through Intensive Technical Assistance |
Professor, University of South Florida, Department of Mental Health Law and Policy Justice Populations with Substance Use and Co-Occurring Mental Disorders |
Department of Psychology, Virginia Commonwealth University Using Patient Surveys as Key Part of your Quality Assurance Plan |
HoGent-University College Ghent, Faculty for Education, Health and Social Work EUPC, the European Universal Prevention Curriculum adaptation and training
|
Photographer, Film Maker and Travel Writer Each person counts: The world drug problem in photographs |
Assistant Director of KETHEA Why Therapeutic Communities are Relevant Today |
|
Chief Drug Prevention and Health Branch Division for Operations United Nations Office on Drugs and Crime Pathogenesis of Substance Use Disorders Cannabis Use For Non-Medical Purposes |
|
Pediatrician, United Nations Office on Drugs and Crime (UNODC) International Standards for the Treatment of Drug Use Disorders |
|
Program Officer, Drug Prevention and Health Branch, UNODC Community Management of Opioid Overdose: Including an Overview of the S-O-S Initiative - Stop Overdose Safely, Treatment and Care for People with Drug Use Disorders in Contact with the Criminal Justice System - Alternatives to Conviction or Punishment The Management of Substance Use and Substance Use Disorders |
|
Preventing the Health Consequences of Substance U Experiences and New Tools from the UNODC Global Programme in Low- and Middle-Income Countries |
|
Associate Director for the Program for Translational Research on Adversity and Neurodevelopment (P-TRAN) Environmental Influences on Neurodevelopmental Trajectories Underlying Risk: Relevance for Substance Use Prevention |
|
Director General National Rehabilitation Center, Abu Dhabi Developing a Hub of Knowledge Transfer: The National Rehabilitation Center Abu Dhabi Training Institute |
|
Programme Management Officer, United Nations on Drug and Crime (UNODC) International Standards on Drug Use Prevention |
|
Director of Colombo Plan Office for Latin America and the Caribbean & UNODC Drug Demand Reduction Policy Maker Trainer Latin America and the Caribbean: Chile an Initiative Implemented in Treatment as Alternatives to Incarceration
|
|
Executive Director International Consortium of Universities for Drug Demand Reduction (ICUDDR) Developing Sustainable Drug Demand Reduction Workforce Development Infrastructure |
|
President, American Association for the Treatment of Opioid Dependence Using Medication-Assisted Treatment to Treat Opioid Use Disorder: Learning from Past Experience to Guide Policy |
|
Professor of Psychiatry Promising Pharmacological Treatments of Stimulant Use Disorder: Time for Translation to Clinical Practice |
|
M.D., Ph.D., D.Med.Sci, Chief, Department of Addictive Disorders, Bekhterev State Psychoneurological Research Institute Naltrexone for Opioid Use Disorders: Oral, Implantable and Injectable |
|
Prof. Dr. Gabriele Fischer, Medical University of Vienna Center for Public Health, Department of Psychiatry & Psychotherapy Gender Specific Treatment Approaches |
|
Bureau of International Narcotics and Law Enforcement Affairs Strengthening the Workforce through Evidence-Based Practices |
|
General Secretary, International Substance Abuse & Addiction Coalition (ISAAC) Connect, Encourage, Equip Supporting Faith-Based Initiatives at Grass-Roots Level |
|
Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV) Neuroscience for Prevention Programmes: Experiences from Mexico |
|
Chief Unit of the Demand Reduction Unit, Executive Secretariat of the Inter-American Drug Abuse Control Commission (CICAD), Organization of American States The Importance of Evaluating Policies to Improve Programmes in Latin America and the Caribbean |
|
Clinical Psychologist Individual Strategies for Relapse Prevention and Semi-Residential Aftercare in Holistic Treatment Models |
|
Psychologist, Pontifical Catholic University of Peru Health Promoting Schools, a Multicomponent Program to Prevent Behavioural Risks Amongst Adolescents in Peru |
|
Alternatives to Incarceration Coordinator, Executive Secretariat of the Inter-American Drug Abuse Control Commission (CICAD), Organization of American States Institutional Capacity in the Implementation of Alternatives to Incarceration under Judicial Supervision for Drug-Related Offenders: A Perspective from the Americas |
|
Assistant Executive Secretary, Inter-American Drug Abuse Control Commission (CICAD), Secretariat for Multidimensional Security Organization of American States The Importance of Evaluating Policies to Improve Programmes in Latin America and the Caribbean |
|
Director, Global Centre for Credentialing and Certification (GCCC) Professionalizing the Workforce to Address Addiction Worldwide |
|
University of Concepción Preventing the Health Consequences of Substance Use |
Dr Dzmitry Krupchanka 
Vladimir Poznyak, MD, PhD
Mark W. Parrino
Dr Adam Bisaga
Dr. Gabriele Fischer 
Treflyn Lloyd-Roberts 
Dr. Silvia L. Cruz
Jimena Kalawski
Dr. Thomas Legl
Edwin Peñaherrera
Antonio Lomba
Angela Crowdy
Becky Vaughn
Dr Carmen Betancur